Horowitz Group

Vibrato Medical is focused on developing a noninvasive therapeutic ultrasound device aimed at treating Critical Limb Ischemia and Peripheral Arterial Disease. The company’s innovative approach is grounded in extensive research and recent advancements in ultrasound technology. Its device is designed to stimulate vasodilation and promote the growth of blood vessels, addressing symptoms and potentially preventing limb loss without the need for surgical intervention. This wearable technology allows patients to benefit from treatment in the comfort of their own homes, making it a convenient and accessible solution for those affected by these serious vascular conditions.

Tarsus Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for ophthalmic conditions, with a pipeline that includes first-in-class candidates aimed at Demodex blepharitis and other eye diseases. Its lead program, TP-03, targets blepharitis caused by Demodex mites and is advancing through Phase IIb/III trials, alongside efforts to address meibomian gland disease. The company is also developing TP-04 for rosacea and TP-05 for Lyme prophylaxis and community malaria reduction, indicating a broader dermatology and infectious-disease focus. Tarsus pursues development across opportunities with unmet medical need, aiming to bring novel therapeutics to patients with limited treatment options. The company was founded in 2016 and is headquartered in Irvine, California.

Metavention, Inc., founded in 2012 and based in Dover, Delaware, specializes in developing innovative treatments aimed at permanently disrupting the overactive nerves that contribute to high blood pressure and various metabolic diseases. The company has created a renal denervation procedure that employs radio frequency energy to target and modulate overactive sympathetic nerves. This trans-catheter device not only addresses issues related to high blood pressure but also focuses on conditions such as Type 2 diabetes by employing standard interventional vascular techniques. By providing physicians with advanced tools for diagnosis and treatment, Metavention aims to enhance patient outcomes for those suffering from metabolic disorders linked to sympathetic nervous system activity.

Founded in 2006 and headquartered in Boston, MiniLuxe operates beauty salons across multiple states in the U.S., offering services such as manicures, pedicures, waxing, and brow treatments. The company also sells gift cards online.